Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Sales | 29,238 | 23,991 | 66,834 | 14,682 | 12,114 |
| Cost of Goods | 488 | 695 | 947 | 594 | 2,395 |
| Gross Profit | 28,750 | 23,296 | 65,887 | 14,088 | 9,719 |
| Operating Expenses | 87,849 | 73,689 | 73,970 | 61,816 | 66,388 |
| Operating Income | -58,611 | -49,698 | -7,136 | -47,134 | -56,274 |
| Interest Expense | 3,813 | 3,856 | 3,764 | 3,720 | 558 |
| Other Income | -436 | 1,092 | 5,400 | 900 | 17 |
| Pre-tax Income | -62,860 | -52,462 | -5,500 | -49,954 | -56,815 |
| Income Tax | 300 | 214 | 251 | 154 | 106 |
| Net Income Continuous | -63,160 | -52,676 | -5,751 | -50,108 | -56,921 |
| Net Income | $-63,160 | $-52,676 | $-5,751 | $-50,108 | $-56,921 |
| EPS Basic Total Ops | -0.33 | -0.28 | -0.03 | -0.27 | -0.30 |
| EPS Basic Continuous Ops | -0.33 | -0.28 | -0.03 | -0.27 | -0.30 |
| EPS Diluted Total Ops | -0.33 | -0.28 | -0.03 | -0.27 | -0.30 |
| EPS Diluted Continuous Ops | -0.33 | -0.28 | -0.03 | -0.27 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.33 | -0.28 | N/A | N/A | N/A |
| EBITDA(a) | $-55,708 | $-46,839 | $-4,401 | $-43,877 | $-54,749 |